ADMISSION ELIGIBILITY CRITERIA
POST-BACCALAUREATE CERTIFICATE PROGRAM
A minimum overall GPA of 2.5 on a 4.0 scale is required.
Recommended preparation for students who will have received their Bachelor’s degree prior to the start of the program:
- 20 credits of science (biology and chemistry courses preferred)
- 3 credits of mathematics or statistics
- A minimum grade point average (GPA) of 3.0 on a 4.0 scale in science coursework
There is currently no option for advanced placement, or counting outside coursework toward program requirements.
3+1 BACHELOR’S PROGRAM
Prospective students may be accepted into the Program after completing three years of undergraduate coursework with an affiliated college or university within the affiliate institution's cytotechnology track. This coursework must include a minimum of:
- 28 credits of biological science and chemistry
- 3 credits of mathematics or statistics
Favorable consideration will be given to applicants with an above average academic record and recommendation.
Students in the 3+1 program enroll at UW-Madison as Special Students.
Applications are due by March 1 for full consideration for the incoming class that starts in August. Applications must include all official college transcripts (not just your most recently attended school) and three letters of recommendation. Interviews are conducted in March and April, and decisions are made in May for an August start. If a class does not fill, late applications and interviews may continue until July.
You may apply online for the program. If admitted to the program you will also be required to submit a UW–Madison special student application to gain student status and become eligible to enroll in your courses.
|GENETICS 470||Basic Cytology and Laboratory Procedures||1|
|GENETICS 570||The Female Reproductive System||8|
|GENETICS 571||Clinical Practice I||1|
|GENETICS 572||The Respiratory System||3|
|GENETICS 573||The Genitourinary System||2|
|GENETICS 471||Advanced Laboratory Procedures||1|
|GENETICS 568||The Central Nervous System||1|
|GENETICS 569||The Breast||1|
|GENETICS 574||The Gastrointestinal System||3|
|GENETICS 575||Miscellaneous Systems||3|
|GENETICS 577||Applied Cytology I||1|
|GENETICS 670||Seminar in Clinical Cytogenetics||1|
|GENETICS 672||Seminar in Laboratory Operations and Quality Control||1|
|GENETICS 673||Seminar in Clinical Cytology||1|
|GENETICS 578||Applied Cytology II||1|
|GENETICS 671||Advanced Clinical Practice||8|
- Establish the biological and medical background knowledge necessary to understand the clinical significance of cytologic diagnoses and related ancillary tests
- Become proficient in screening of gynecologic and nongynecologic slides for rare findings, including developing the accuracy and speed expected by future employers
- Develop diagnostic accuracy and speed as expected by future employers
- Demonstrate professional and ethical standards of conduct within the medical laboratory
Professional Certification/Licensure Disclosure (NC-SARA)
The United States Department of Education requires institutions that provide distance education to disclose information for programs leading to professional certification or licensure about whether each program meets state educational requirements for initial licensure or certification. Following is this disclosure information for this program:
The requirements of this program meet Certification/Licensure in the following states:
Alabama, Arizona, Colorado, Illinois, Washington, Wisconsin
The requirements of this program do not meet Certification/Licensure in the following states:
The requirements of this program have not been determined if they meet Certification/Licensure in the following states:
Alaska, Arkansas, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, West Virginia, Wyoming; District of Columbia; American Samoa, Guam, Northern Mariana Islands, Puerto Rico, U.S. Virgin Islands
Accreditation status: Accredited. Next accreditation review: 2023.
On recommendation of the Cytotechnology Programs Review Committee, sponsored by the American Society of Cytology.